Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapy of diabetes and dyslipidemia in acromegaly.

Literature DB >> 12638723

Therapy of diabetes and dyslipidemia in acromegaly.

G Tamburrano¹, C Durante, R Baldelli.

Abstract

Entities: Disease

Mesh：

Year: 2002 PMID： 12638723 DOI： 10.1023/a:1022101417810

Source DB: PubMed Journal: Pituitary ISSN： 1386-341X Impact factor: 4.107

× No keyword cloud information.

45 in total

1. Serum lipids in acromegaly.

Authors: E A Nikkilä; R Pelkonen
Journal: Metabolism Date: 1975-07 Impact factor: 8.694

2. Insulin secretion and sensitivity in acromegaly.

Authors: T S Jap; L T Ho
Journal: Clin Physiol Biochem Date: 1990

3. Acute metabolic effects of human growth hormone.

Authors: S E Fineberg; T J Merimee
Journal: Diabetes Date: 1974-06 Impact factor: 9.461

4. Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro.

Authors: J W Kolaczynski; M R Nyce; R V Considine; G Boden; J J Nolan; R Henry; S R Mudaliar; J Olefsky; J F Caro
Journal: Diabetes Date: 1996-05 Impact factor: 9.461

5. Sandostatin LAR in acromegalic patients: long-term treatment.

Authors: A K Fløgstad; J Halse; S Bakke; I Lancranjan; P Marbach; C Bruns; J Jervell
Journal: J Clin Endocrinol Metab Date: 1997-01 Impact factor: 5.958

Review 6. The role of leptin in reproduction: experimental and clinical aspects.

Authors: Roberto Baldelli; Carlos Dieguez; Felipe F Casanueva
Journal: Ann Med Date: 2002 Impact factor: 4.709

7. Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center.

Authors: G Barrande; M Pittino-Lungo; J Coste; D Ponvert; X Bertagna; J P Luton; J Bertherat
Journal: J Clin Endocrinol Metab Date: 2000-10 Impact factor: 5.958

8. A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed meal.

Authors: C Parkinson; W M Drake; M E Roberts; K Meeran; G M Besser; P J Trainer
Journal: J Clin Endocrinol Metab Date: 2002-04 Impact factor: 5.958

Therapy of diabetes and dyslipidemia in acromegaly.

1. Serum lipids in acromegaly.

2. Insulin secretion and sensitivity in acromegaly.

3. Acute metabolic effects of human growth hormone.

4. Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro.

5. Sandostatin LAR in acromegalic patients: long-term treatment.

Review 6. The role of leptin in reproduction: experimental and clinical aspects.

7. Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center.

8. A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed meal.

9. Effect of octreotide on glucose tolerance in acromegaly.

10. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM.

Review 1. Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis.

Review 2. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.